BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/13/2019 3:36:14 AM | Browse: 487 | Download: 479
Category |
Orthopedics |
Manuscript Type |
Randomized Controlled Trial |
Article Title |
Single- and double-dose of platelet-rich plasma versus hyaluronic acid for treatment of knee osteoarthritis: A randomized controlled trial
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Mehdi Tavassoli, Nasser Janmohammadi, Akram Hosseini, Soraya Khafri and Seyed Mokhtar Esmaeilnejad-Ganji |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Vice Chancellor for Research and Technology of Babol University of Medical Sciences |
970568 |
|
Corresponding Author |
Seyed Mokhtar Esmaeilnejad-Ganji, MD, Associate Professor, Attending Doctor, Surgeon, Department of Orthopedics, Babol University of Medical Sciences, Ganjafrooz Street, Babol 47176-47745, Mazandaran, Iran. smsnganji@yahoo.com |
Key Words |
Platelet-rich plasma; Hyaluronic acid; Osteoarthritis; Knee; Pain; |
Core Tip |
Studies comparing the efficacy of platelet-rich plasma (PRP) and hyaluronic acid in treatment of knee osteoarthritis are insufficient. In this randomized controlled trial study, we compared the outcomes of PRP versus hyaluronic acid injections in three groups of patients with bilateral knee osteoarthritis. It was observed that PRP is significantly more efficient than hyaluronic acid. We also found that the efficacy of PRP increases after multiple injections. PRP was a safe treatment in our study and no major adverse effects were found. |
Citation |
Tavassoli M, Janmohammadi N, Hosseini A, Khafri S, Esmaeilnejad-Ganji SM. Single- and double-dose of platelet-rich plasma versus hyaluronic acid for treatment of knee osteoarthritis: A randomized controlled trial. World J Orthop 2019; 10(9): 310-326 |
|
Received |
|
2019-03-06 09:20 |
|
Peer-Review Started |
|
2019-03-08 03:30 |
|
To Make the First Decision |
|
2019-04-16 07:34 |
|
Return for Revision |
|
2019-05-09 09:45 |
|
Revised |
|
2019-05-10 14:51 |
|
Second Decision |
|
2019-08-09 02:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-08-13 03:36 |
|
Articles in Press |
|
2019-08-13 03:36 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-09-04 21:52 |
|
Typeset the Manuscript |
|
2019-09-11 09:05 |
ISSN |
2218-5836 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345